{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:42:59Z","timestamp":1791434579546,"version":"4.3.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Vidi grant (Knibbe"],"award-info":[{"award-number":["Vidi grant (Knibbe"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["May 2013)"],"award-info":[{"award-number":["May 2013)"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s40262-018-0652-7","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T07:19:21Z","timestamp":1521789561000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Influence of Normalization Weight in Population Pharmacokinetic Covariate Models"],"prefix":"10.1007","volume":"58","author":[{"given":"Sebastiaan C.","family":"Goulooze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swantje","family":"V\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyry A. J.","family":"V\u00e4litalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa A. M.","family":"Calvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Aarons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke H. J.","family":"Krekels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1038\/psp.2012.4","volume":"1","author":"DR Mould","year":"2012","unstructured":"Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharmacometrics Syst Pharmacol. 2012;1:e6.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1038\/psp.2013.14","volume":"2","author":"DR Mould","year":"2013","unstructured":"Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development\u2014part 2: introduction to pharmacokinetic modeling methods. CPT Pharmacometrics Syst Pharmacol. 2013;2:e38.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ejps.2017.05.022","volume":"109S","author":"EHJ Krekels","year":"2017","unstructured":"Krekels EHJ, van Hasselt JGC, van den Anker JN, Allegaert K, Tibboel D, Knibbe CAJ. Evidence-based drug treatment for special patient populations through model-based approaches. Eur J Pharm Sci. 2017;109S:S22\u20136.","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"652_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00431-006-0189-x","volume":"165","author":"BJ Anderson","year":"2006","unstructured":"Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr. 2006;165(12):819\u201329.","journal-title":"Eur J Pediatr"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","volume":"48","author":"BJ Anderson","year":"2008","unstructured":"Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol. 2008;48:303\u201332.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"652_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/pharmaceutics2040389","volume":"2","author":"R Shi","year":"2010","unstructured":"Shi R, Derendorf H. Pediatric dosing and body size in biotherapeutics. Pharmaceutics. 2010;2(4):389\u2013418.","journal-title":"Pharmaceutics"},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010814-124354","volume":"55","author":"CA Knibbe","year":"2015","unstructured":"Knibbe CA, Brill MJ, van Rongen A, Diepstraten J, van der Graaf PH, Danhof M. Drug disposition in obesity: toward evidence-based dosing. Annu Rev Pharmacol Toxicol. 2015;55:149\u201367.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"11","key":"652_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2165\/11594080-000000000-00000","volume":"50","author":"DJ Eleveld","year":"2011","unstructured":"Eleveld DJ, Proost JH, Absalom AR, Struys MM. Obesity and allometric scaling of pharmacokinetics. Clin Pharmacokinet. 2011;50(11):751\u20133 (discussion 5\u20136).","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"652_CR9","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s40262-017-0542-4","volume":"56","author":"I Mahmood","year":"2017","unstructured":"Mahmood I, Tegenge MA. Population pharmacokinetics: some observations in pediatric modeling for drug clearance. Clin Pharmacokinet. 2017;56(12):1567\u201376.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"652_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","volume":"30","author":"NH Holford","year":"1996","unstructured":"Holford NH. A size standard for pharmacokinetics. Clin Pharmacokinet. 1996;30(5):329\u201332.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"652_CR11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1213\/ANE.0000000000001257","volume":"122","author":"DM Fisher","year":"2016","unstructured":"Fisher DM, Shafer SL. Allometry, Shallometry! Anesth Analg. 2016;122(5):1234\u20138.","journal-title":"Anesth Analg"},{"issue":"3","key":"652_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40262-016-0436-x","volume":"56","author":"EA Calvier","year":"2017","unstructured":"Calvier EA, Krekels EH, Valitalo PA, Rostami-Hodjegan A, Tibboel D, Danhof M, et al. Allometric scaling of clearance in paediatric patients: when does the magic of 0.75 fade? Clin Pharmacokinet. 2017;56(3):273\u201385.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"652_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/0091270011422812","volume":"52","author":"Y Wang","year":"2012","unstructured":"Wang Y, Jadhav PR, Lala M, Gobburu JV. Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies. J Clin Pharmacol. 2012;52(10):1601\u20136.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"652_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1208\/s12248-012-9320-2","volume":"14","author":"M Joerger","year":"2012","unstructured":"Joerger M. Covariate pharmacokinetic model building in oncology and its potential clinical relevance. AAPS J. 2012;14(1):119\u201332.","journal-title":"AAPS J"},{"key":"652_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9485-1","volume-title":"Pharmacokinetic-pharmacodynamic modeling and simulation","author":"PL Bonate","year":"2011","unstructured":"Bonate PL. Pharmacokinetic-pharmacodynamic modeling and simulation. 2nd ed. New York: Springer; 2011.","edition":"2"},{"issue":"2","key":"652_CR16","first-page":"83","volume":"38","author":"RD Snee","year":"1984","unstructured":"Snee RD, Marquardt DW. Comment: collinearity diagnostics depend on the domain of prediction, the model, and the data. Am Stat. 1984;38(2):83\u20137.","journal-title":"Am Stat"},{"issue":"2","key":"652_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00031305.1984.10483169","volume":"38","author":"DA Belsley","year":"1984","unstructured":"Belsley DA. Demeaning conditioning diagnostics through centering. Am Stat. 1984;38(2):73\u20137.","journal-title":"Am Stat"},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.ejps.2017.05.026","volume":"109S","author":"S Voller","year":"2017","unstructured":"Voller S, Flint RB, Stolk LM, Degraeuwe PLJ, Simons SHP, Pokorna P, et al. Model-based clinical dose optimization for phenobarbital in neonates: an illustration of the importance of data sharing and external validation. Eur J Pharm Sci. 2017;109S:S90\u20137.","journal-title":"Eur J Pharm Sci"},{"key":"652_CR19","first-page":"220","volume-title":"NONMEM users guide\u2014part VIII","author":"AJ Boeckmann","year":"2010","unstructured":"Boeckmann AJ, Sheiner LB, Beal SL. NONMEM users guide\u2014part VIII. Ellicott City: ICON Development Solutions; 2010. p. 220."},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1038\/psp.2013.24","volume":"2","author":"RJ Keizer","year":"2013","unstructured":"Keizer RJ, Karlsson MO, Hooker A. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacometrics Syst Pharmacol. 2013;2:e50.","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-018-0652-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-018-0652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-018-0652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T07:07:41Z","timestamp":1719904061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-018-0652-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s40262-018-0652-7","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"23 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. Details on the ethical approval and informed consent from the previously published clinical studies of which the anonymized data was used as a case example are reported elsewhere [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Catherijne A. J. Knibbe was supported by the Innovational Research Incentives Scheme of the Dutch Organization for Scientific Research (NWO, Vidi grant, May 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Sebastiaan C. Goulooze, Swantje V\u00f6ller, Pyry A. J. V\u00e4litalo, Elisa A. M. Calvier, Leon Aarons, Elke H.J. Krekels, and Catherijne A.J. Knibbe have no conflicts of interest that are relevant to the content of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}